American Heart Association. 2002 Heart and Stroke Statistical Up-date. Dallas, TX: American Heart Association, 2001.

Kim MC, Kini A, Sharma SK. Refractory angina pectoris: mechanism and therapeutic options. J Am Coll Cardiol 2002;39:923–34.

Stys T, Lawson WE, Hui JCK, Lang G, Liuzzo J, Cohn PF. Acute hemodynamic effects and angina improvement with enhanced external counterpulsation. Angiology 2001;52:653–8.

Zheng ZS, Li TM, Kambic H, et al. Sequential external counterpulsation (SECP) in China. Trans Am Soc Artif Intern Organs 1983; 29:599 –603.

Lawson WE, Hui JCK, Soroff HS, et al. Efficacy of enhanced external counterpulsation in the treatment of angina pectoris. Am J Cardiol 1992;70:859 –62.

Lawson WE, Hui JCK, Zheng ZS, et al. Can angiographic findings predict which coronary patients will benefit from enhanced external counterpulsation? Am J Cardiol 1996;77:1107–9.

Lawson WE, Hui JCK, Guo T, Burger L, Cohn PF. Prior revascularization increases the effectiveness of enhanced external counterpulsation. Clin Cardiol 1998;21:841–4.

Lawson WE, Hui JCK, Cohn PF. Long-term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up study. Clin Cardiol 2000;23:254 –8.

Stys TP, Lawson WE, Hui JCK, et al. Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. Am J Cardiol 2002;89:822–4.

Masuda D, Nohara R, Hirai T, et al. Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina. Eur Heart J 2001;22:1451–8.

Lawson WE, Hui JCK, Zheng ZS, et al. Improved exercise tolerance following enhanced external counterpulsation: cardiac or peripheral effect? Cardiology 1996;87:271–5.

Urano H, Ikeda H, Ueno T, Matsumoto T, Murohara T, Imaizumi T. Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol 2001;37:93–9.

Fricchione GL, Jaghab K, Lawson W, et al. Psychosocial effects of enhanced external counterpulsation in the angina patient. Psychoso-matics 1995;36:494 –7.

Springer S, Fife A, Lawson W, et al. Psychosocial effects of enhanced external counterpulsation in the angina patient: a second study. Psychosomatics 2001;42:124 –32.

Arora RR, Chou TM, Jain D, et al. The Multicenter Study of Enhanced External Counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol 1999;33:1833–40.

Arora RR, Chou TM, Jain D, et al. Effects of enhanced external counterpulsation on health-related quality of life continue 12 months after treatment: a substudy of the multicenter study of enhanced external counterpulsation. J Investig Med 2002;50:25–32.

Barsness G, Feldman AM, Holmes DR Jr., Holubkov R, Kelsey SF, Kennard ED, and the International EECP Patient Registry Investigators. The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results. Clin Cardiol 2001;24:435–42.

Lawson WE, Hui JCK, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology 2000;94:31–5.

Lawson WE, Hui JCK, Zheng ZS, et al. Three-year sustained benefit from enhanced external counterpulsation in chronic angina pectoris. Am J Cardiol 1995;75:840 –1.

Michaels AD, Accad M, Ports TA, Grossman W. Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation. Circulation 2002;106:1237–42.

Barsness GW. Enhanced external counterpulsation in unrevascularizable patients. Curr Interv Cardiol Rep 2001;3:37–43.

Werner D, Schneider M, Weise M, Nonnast-Daniel B, Daniel WG. Pneumatic external counterpulsation: a new noninvasive method to improve organ perfusion. Am J Cardiol 1999;84:950 –2.

Suresh K, Simandl S, Lawson WE, et al. Maximizing the hemodynamic benefit of enhanced external counterpulsation. Clin Cardiol 1998;21:649 –53.

Michaels AD, Kennard ED, Kelsey SF, et al. Does higher diastolic augmentation predict clinical benefit from enhanced external counter-pulsation? Data from the International EECP Patient Registry (IEPR). Clin Cardiol 2001;24:453–8.

Lakshmi MV, Kennard ED, Kelsey SF, Holubkov R, Michaels AD. Relation of the pattern of diastolic augmentation during a course of enhanced external counterpulsation (EECP) to clinical benefit (from the International EECP Patient Registry [IEPR]). Am J Cardiol 2002;89:1303–5.

Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 1997;30:325–33.

Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801–9.

Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003;23:168 –75.

Lerman A, Burnett JC Jr. Intact and altered endothelium in regulation of vasomotion. Circulation 1992;86 Suppl III:12–9.

Kern MJ, Aguirre FV, Tatineni S, et al. Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients. J Am Coll Cardiol 1993;21:359 –68.

Kern MJ, Aguirre F, Bach R, Donohue T, Siegel R, Segal J. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation 1993;87:500 –11.

Corson MA, James NL, Latta SE, Nerem RM, Berk BC, Harrison DG. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res 1996;79:984 –91.

Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999;399:601–5.

Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev 1995;75:519 –60.

Kuchan MJ, Frangos JA. Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am J Physiol 1993;264:H150–6.

Niebauer J, Cooke JP. Cardiovascular effects of exercise: role of endothelial shear stress. J Am Coll Cardiol 1996;28:1652–60.

Traub O, Berk BC. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol 1998;18:677–85.

Masuda D, Nohara R, Hirai T, et al. Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina. Eur Heart J 2001;22:1451–8.

Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000;87:840 –4.

Lawson WE, Hui JCK, Lu L, Zheng ZS, Zhang MQ. Beneficial effects of EECP on the reninangiotension system in patients with coronary artery disease (abstr). Eur Heart J 2001;22 Suppl:538.

Mollnau H, Wendt M, Szo¨ cs K, et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 2002;90:e58 – 65.

Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolino AP, Cockcroft JR. Nitric oxide regulates local arterial distensibility in vivo. Circulation 2002;105:213–7.

Kersten JR, Pagel PS, Chilian WM, Warltier DC. Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia. Cardiovasc Res 1999;43:44 –57.

Cai D, Wu R, Shao Y. Experimental study of the effect of external counterpulsation on blood circulation in the lower extremities. Clin Invest Med 2000;23:239 –47.

Van Royen N, Piek JJ, Buschmann I, et al. Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc Res 2001;49:543–53.

Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242–8.

Gan L, Miocic M, Doroudi R, Selin-Sjögren L, Jern S. Distinct regulation of vascular endothelial growth factor in intact human conduit vessels exposed to laminar fluid shear stress and pressure. Biochem Biophys Res Commun 2000;272:490 –6.

Resnick N, Collins T, Atkinson W, Bonthron DT Dewey CF Jr., Gimbrone MA. Platelet-derived growth factor B chain promoter contains a cis-acting shear-stress-responsive element. Proc Natl Acad Sci USA 1993;90:4591–5.

Masuda D, Nohara K, Kataoka K, Hosokawa R, Kanbara N, Fujita M. Enhanced external counterpulsation promotes angiogenesis factors in patients with chronic stable angina (abstr). Circulation 2001;104: II445.

Van Belle E, Witzenbichler B, Chen D, et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor. Circulation 1998;97:381–90.

Ziche M, Morbidelli L. Nitric oxide and angiogenesis. J Neurooncol 2000;50:139 –48.

Hood JD, Meininger CJ, Ziche M, Granger HJ. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 1998;274:H1054–8.

Papapetropoulos A, García Cardeña G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997;100:3131–9.

Fulton D, Gratton JP, McCabe TJ, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase. Akt Nature 1999;399:597–601.

Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 1993;265:H586–92.

Murohara T, Asahara T, Silver M, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998;101:2567–78.

Freedman SB, Isner JM. Therapeutic angiogenesis for coronary artery disease. Ann Intern Med 2002;136:54 –71.

Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bonemarrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434 –8.

Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18:3964 –72.

Kalka C, Masuda H, Takahashi T, et al. Vascular endothelial growth factor165 gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 2000;86:1198 –202.

Cohen LS, Mullins CB, Mitchell JH, Alsobrook HD. Sequenced external counterpulsation and intraaortic balloon pumping in cardiogenic shock. Am J Cardiol 1973;32:656 –61.

Singh M Holmes DR Jr., Tajik AJ, Barsness GW. Noninvasive revascularization by enhanced external counterpulsation: a case study and literature review. Mayo Clin Proc 2000;75:961–5.

Gorcsan J III, Crawford L, Soran O, et al. Improvement in left ventricular performance by enhanced external counterpulsation in patients with heart failure. J Am Coll Cardiol 2000;35 Suppl:230A.

Soran OZ, Fleishman B, DeMarco T, et al. Enhanced external counterpulsation in patients with heart failure: a multicenter feasibility study. Congest Heart Fail 2002;8:204 –8.

Soran O, Kennard ED, Holubkov R, Strobeck J, Feldman AM. Six month outcome of patients with left ventricular dysfunction treated with enhanced external counterpulsation for chronic angina. Eur Heart J 2000;21 Suppl:598.

Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have enhanced placebo effects? J Clin Epidemiol 2000;53:786 –92.